This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Intensity determined the extent to which certain patents in the field of molecular diagnostics were unenforceable due to prosecution laches. Intensity also performed an analysis of damages relating to alleged infringement of patented technology by quantifying reasonable royalties.
Intensity was retained to analyze the ongoing investments, marketing, and research in a biotechnology company specializing in molecular diagnostics. Intensity assessed the extent to which these were or were not sunk costs and the extent to which these costs precluded alternative research and investment spending. Intensity then determined a reasonable and market-based royalty for technology as part of molecular diagnostics testing kits, based on consideration of the market for these kits, the licensing policies and histories of both companies, product sales and profitability.
Intensity also performed an analysis of damages relating to alleged infringement of patented technology by quantifying reasonable royalties based on consideration of relevant licensing agreements, accused sales and profitability, and the unique contribution of the patented technology.
Economic issues include apportionment, licensing, and reasonable royalties.
Paris Arbitration Week 2025 Recap
Secretariat was a proud supporting partner of Paris Arbitration Week (PAW) 2025. The event, which took place from April 7 to 11, brought together more than 10,000 arbitration practitioners from 135 countries. We were thrilled to participate in dynamic discussions, host insightful panels, and share our passion and expertise with the international arbitration community.
Global Financial and Economic Crime Outlook 2025
Our Global Financial and Economic Crime Risk Outlook 2025 provides an in-depth, data-driven analysis of these emerging threats, helping businesses navigate the complexities of financial crime with confidence.
Beyond the Buyout: Domino’s Done but Other Deals Stuck in SE Asia
Managing Director Charlie Warren explores the impact of consumer boycotts on M&A in Southeast Asia in Deal Street Asia’s latest article, Beyond the Buyout.